Enterococcus faecalis, an organism generally not pathogenic for healthy humans, has the potential to cause disease in susceptible hosts. While it seems to be equipped to interact with and circumvent host immune defense, most of the molecular and cellular mechanisms underlying the enterococcal infectious process remain elusive. Here, we investigated the role of the Enterococcal Leucine Rich protein A (ElrA), an internalin-like protein of E. faecalis also known as a virulence factor. ElrA was previously shown to prevent adhesion to macrophages. We show that ElrA does not inhibit the basic phagocytic process, but is able to prevent sensing and migration of macrophages toward E. faecalis. Presence or absence of FHL2, a eukaryotic partner of ElrA, does not affect the ElrA-dependent mechanism preventing macrophage migration. However, we highlight a partial contribution of FHL2 in ElrA-mediated virulence in vivo. Our results indicate that ElrA plays at least a dual role of which anti-phagocytic activity may contribute to dissemination of extracellular E. faecalis during infection.
adhesion to macrophages 9 . Recently, a physical interaction between ElrA and FHL2, a human member of the four-and-a-half-LIM-only protein family has been revealed using a two-hybrid screen in yeast 10 . Interestingly, deletion of the FHL2-interacting domain of ElrA decreased E. faecalis infectivity in Balb/c mice after intravenous and urinary tract infections 10 . FHL2 is formed of LIM domains involved in several protein-protein interactions and participates in a wide range of cellular processes including cellular transcription, signal transduction and cell survival or death 11 . Such broad roles for FHL2 opens up a wide spectrum of possibilities for FH2 contribution in E. faecalis virulence. Moreover, while the role of ElrA in E. faecalis virulence is clearly established, how ElrA-expressing E. faecalis escapes macrophage phagocytosis remains poorly understood.
In this study, we aimed to further investigate ElrA-dependent mechanisms that prevent E. faecalis binding to macrophages and favor E. faecalis evasion from macrophage phagocytosis. Using the genetically modified P + -elrA-E strain and isogenic strains expressing or not expressing ElrA, we assessed the capacity of other cell types to internalize ElrA-expressing E. faecalis. We also evaluated whether ElrA modifies the structure of the enterococcal population or bacterial surface properties in such a way that macrophages would not be able to recognize E. faecalis. We investigated whether disruption of FHL2, an ElrA partner, impacts on this process.
Results
ElrA expression impacts upon structure of the enterococcal population without major changes in E. faecalis. The elrA-E operon is predicted to encode a protein complex at the bacterial surface, where ElrA expression may increase surface negative charge during cell infection to prevent macrophage adhesion 5, 9 . Here, we performed a series of in vitro assays to establish which observable characteristics conferred by ElrA expression may be prevailing to prevent cell adhesion and ultimately macrophage phagocytosis.
First, to assess if ElrA expression modifies E. faecalis surface charge, we evaluated the electric potential at the bacterial surface, known as zeta potential. Experiments were carried out on four isogenic strains expressing or not expressing ElrA (Table 1 and Supp. Figure 1) . Bacterial surface components are ionized according to environmental pH. The use of an electric field triggers bacterial migration towards the electrode of opposite charge of its global charge with a velocity proportional to the magnitude of the zeta potential 12 . We thus measured the electrophoretic motility of these four elrA isogenic strains, at pH 7, like in conditions of cell infection. Using the Smoluchowski equation 13 , we determined the zeta potential values (ζ) as follows ζ(OG1RF) = −36.2 ± 1.0 mV, ζ(P + -elrA-E) = −29.9 ± 2.8 mV, ζ(P + -ΔelrA) = −34.8 ± 1.4 mV, ζ(CPL-elrA) = −32.9 ± 2.2 mV. All the tested strains have a dominant negative charge consistent with an electronegative zeta potential value, indicating that in conditions of cell infection, where the pH is neutral, ElrA expression does not increase surface negative charge.
We also investigated whether unlocking expression of the elrA-E operon induces a modification of the cell wall composition. Both P + -elrA-E and P + -ΔelrA strains exhibit a similar profile to that of the wild type strain with a cyan blue band corresponding to the rhamnopolysaccharide Epa and a black band corresponding to the teichoïc acids (Fig. 1A) . These results showed that the major composition of surface polysaccharides is conserved in the elrA isogenic strains. Moreover, measurement of the different layers of the bacterial envelope by transmission electron microscopy showed that both wild type and P + -elrA-E strains had similar thickness for the polysaccharide pellicle (8.1 ± 0.8 nm and 8.7 ± 1.0 nm, respectively), the intermediate translucent region (11.7 ± 1.6 nm and 11.5 ± 0.8 nm, respectively) and the peptidoglycan layer (16.5 ± 1.3 nm and 16.8 ± 1.6 nm, respectively) (Fig. 1B) . The morphology and structure of the cell wall as well as the content of surface polysaccharides between strains thus remain identical whether or not expressing ElrA.
Next, we compared the development and the cohesion of biofilms formed by E. faecalis grown statically using confocal microscopy. We first examined the biofilms formed by the different strains in the absence of washes. While very few floating bacteria were found with the OG1RF and P + -ΔelrA strains, the P + -elrA-E and CPL-elrA strains remained mainly planktonic and floating bacteria were observed, suggesting that ElrA-expressing E. faecalis does not form a solid biofilm (Fig. 2A) . The strength of the different biofilms was followed after bacterial incubation and washes. We observed that biofilms of the OG1RF and P + -ΔelrA strains were formed and well-attached to the well surface (Fig. 2B, left panels) . In contrast, biofilms of the P + -elrA-E strain was easily disrupted after the washes and bacteria were poorly attached to the abiotic surface. In agreement with these observations, the corresponding biomass of the P + -elrA-E strain was ~50% thinner compared to the wild type and P + -ΔelrA strains (Fig. 2B, right panel) . A similar trend was observed with the CPL-elrA strain (Fig. 2B, lower rightest panel) . Consistently, the P + -elrA-E strain produced biofilms were 3 times less cohesive than those of the wild type and P + -ΔelrA strains (Supp. Figure 2 ), indicating that ElrA promotes a loss of cohesion between bacteria. No notable differences regarding charge, morphology, cell wall structure and surface polysaccharides content was noted between strains, indicating that ElrA expression does not induce major changes that interfere with macrophage recognition. However, ElrA promotes a loss of cohesion between bacteria triggering a free-floating state that may affect contact with macrophages.
ElrA confers an anti-phagocytic activity when bacterial contact with macrophages and non-professional phagocytic cells is forced. To test whether forcing contact of bacteria to macrophages would circumvent the lack of adherence 14 , we decided to constrain bacteria to reach macrophages in a phagocytosis assay where bacteria were centrifuged with the cells. The capacity of ElrA-expressing E. faecalis to be internalized into macrophages was evaluated by determining the percentage of invasion as the ratio of internalized bacteria 1 hour post-infection (p.i.) relative to the initial inoculum. Professional phagocytic Raw264.7 macrophages engulfed 50% of the initial inocula of the wild type and P + -ΔelrA bacteria (Fig. 3) . Strikingly, less than 20% of the P + -elrA-E bacteria were internalized, showing that, although forcing contact, the efficiency of P + -elrA-E bacteria adhesion or internalization was lower than that of the wild type. These data indicated that ElrA still confers an anti-phagocytic activity even when bacteria are in contact with macrophages.
During infection, E. faecalis also encounters non-professional phagocytes. We investigated whether ElrA-mediated escape was a more general mechanism. We performed the same invasion assay in seven human cell lines, all derived from tissues potentially targeted by E. faecalis during host infection. In contrast to what we observed for macrophages, the percentage of internalized wild-type E. faecalis was 2-4 orders of magnitude lower in non-immune cells (Fig. 3) . The percentage of invasion reached almost 0.4% in placental cells (Jeg-3), but was only about <0.004% in hepatic cells (HepG2) and ~0.001% in epithelial cervical (Hela) cells. It oscillated between 0.01% and 0.05% in fibroblastic kidney cells (ACHN), in colonic epithelial cells (Caco-2), in ileocecal epithelial cells (HCT-8) and in epithelial kidney cells (A-704). Except for cervical epithelial and renal fibroblastic cells, we recovered a significant lower number of internalized P + -elrA-E bacteria compared to the wild type strain and to the P + -ΔelrA strain (Fig. 3) . These results showed that ElrA expression prevents E. faecalis internalization in various cell types, suggesting that ElrA-mediated escape is a general mechanism to circumvent host defense.
ElrA does not block phagocytosis per se, but impairs migration of macrophages toward ElrA-expressing E. faecalis. Because forced contact is not sufficient to restore full adhesion of ElrA-expressing E. faecalis to host cells, we tested whether ElrA hampers macrophage capacity to engulf particles. We incubated macrophages with the P + -elrA-E strain, which constitutively expresses the operon, or with purified ElrA prior to incubation with fluorescent beads and quantified the percentage of bead-positive macrophages by flow cytometry. We found that around 85% of untreated macrophages were able to phagocytize fluorescent beads (Fig. 4A ). When incubated with the P + -elrA-E strain or purified ElrA, macrophages phagocytized beads with the same efficacy, demonstrating that neither released nor surface-bound form of ElrA interfered with macrophage capacity to phagocytize. These results showed that ElrA does not inhibit the intrinsic capacity of macrophages to phagocytize, suggesting that ElrA may hinder mechanisms upstream of the phagocytic process, such as bacterial sensing by macrophages. To test this hypothesis, we used a modified Boyden chamber, such that macrophages were seeded in the upper compartment of the chamber and one of the four E. faecalis isogenic strains expressing or not ElrA were incubated in the lower chamber. In this assay, macrophages are entrapped in the membrane separating the two compartments if they sense and migrate toward the bacteria in the lower chamber. The results showed that 104 ± 26 macrophages migrated toward bacteria when exposed to the E. faecalis wild type strain; this rate of migration was 5-fold higher than random migration of macrophages in the absence of infection (P = 0.0112) (Fig. 4B ). Similar numbers of migrating OG1RF-exposed macrophages were counted when exposed to the P + -ΔelrA strain. Strikingly, we observed that macrophages did not migrate toward the P + -elrA-E and CPL-elrA strains, both overexpressing ElrA. In a similar way to what we observed in the absence of infection, only 20 ± 5 macrophages migrated in these conditions (Fig. 4B ). This finding showed that macrophages do not migrate toward ElrA-expressing E. faecalis, indicating that ElrA-expressing E. faecalis are not sensed by macrophages.
Inhibition of macrophage migration is independent of FHL2-ElrA interaction. ElrA can be both exposed at the bacterial surface and released in the culture supernatant 7 . A eukaryotic interactive target of ElrA is FHL2 10 . We investigated whether FHL2-ElrA interaction was involved in preventing macrophage migration. The migration assay was performed with bone-marrow macrophages (BMDMs) differentiated from C57BL/6 J wild type or FHL2 −/− mice. In both cases, we observed that BMDMs did not migrate toward ElrA-expressing E. faecalis (Fig. 5A ). These data substantiate the effect of ElrA in inhibiting sensing and migration of macrophages, albeit independently of FHL2.
Because deletion of the FHL2-interacting domain of ElrA impacts infection in vivo 10 , we investigated the role of FHL2 during E. faecalis infection by challenging FHL2 −/− mice versus wild-type C57BL/6 mice upon intravenous infection for 24 h with E. faecalis. Both mice were challenged with OG1RF and the ΔelrA strain since ElrA is expressed in vivo 5 . Different trends were observed depending on the organ invaded by E. faecalis (Fig. 5B ). FHL2 was found to play a role in defense against E. faecalis in the spleen and in the kidneys but not in the liver. In the spleen, FHL2 defense against E. faecalis would be triggered by ElrA. Together, these data showed that FHL2 is involved in controlling E. faecalis infection and FHL2 may counteract ElrA action in the spleen to prevent E. faecalis burden. The different phenotypes observed in vivo among the various organs suggest that ElrA and FHL2 have differential roles depending on the conditions encountered by E. faecalis during infection.
Discussion
ElrA is an internalin-like protein implicated in prevention of macrophage adhesion and E. faecalis evasion from macrophage phagocytosis 9 . In this study, we explored the mechanism of action of ElrA. We ruled out the possibilities that electric repulsion between the bacterial and eukaryotic cell surface or that major structural changes in E. faecalis envelope are responsible for ElrA-dependent escape. ElrA confers a free floating state to ElrA-expressing bacteria, which is not responsible for the inability of E. faecalis to adhere to macrophages. Moreover, we showed that ElrA does not block macrophage capacity to phagocytize. Instead, we demonstrated that macrophages remain insensitive to and do not migrate towards ElrA-expressing E. faecalis. Of note, ElrA-mediated escape occurs in some non-professional phagocytic cells. We also investigated the role of FHL2, a eukaryotic partner of ElrA. In vivo, we showed that FHL2 is involved in E. faecalis infection, but with a partial contribution relying on its interaction with ElrA, suggesting that FHL2-ElrA interaction may be involved in processes other than phagocytosis escape during E. faecalis infection. Together, our results pointed to ElrA acting as an anti-phagocytic cloak allowing E. faecalis to be undetected by host cells. E. faecalis strains synthesizing a capsule have a reduced complement and antibody-mediated opsonization compared to unencapsulated strains 15, 16 . Using genetically engineered immunocompromised zebrafish, the Epa rhamnopolysaccharide was also shown to allow host phagocytosis evasion 17 . In this work, we used the unencapsulated strain OG1RF and found that ElrA expression in vitro does not impact on the production of Enterococcal polysaccharide antigen (Epa) and of teichoïc acids present in E. faecalis envelope. The integrity of these latter components suggests that ElrA-expressing E. faecalis has the potential to remain phagocytized even if we cannot exclude that peptidoglycan-bound ElrA may mask PAMPs (Pathogen Associated Molecular Patterns) at the bacterial surface. In this study, we also found that at neutral pH ElrA expression does not alter the global charge, which remains negative and identical to that of bacteria not expressing ElrA. Previous physico-chemical studies have shown that E. faecalis has also a predominant negative charge at its surface 18, 19 . It has been recently shown that anchored proteins in the host cell membrane provide a local positive charge indicating that negatively-charged pathogens can efficiently infect eukaryotic cells, despite a global negatively charged surface 20 .
To our knowledge, we report for the first time an inhibition of macrophage sensing triggered by an internalin-like protein. An inhibition of chemoattraction of macrophages towards bacteria has been observed in S. aureus, where the secretion of chemotaxis inhibitory protein (CHIP) and formyl peptide receptor-like 1 inhibitors bind to the formylated peptide receptor directly avoiding chemoattraction of neutrophils 21 . Moreover, the secretion of the cysteine protease staphopain cleaves CXCR2 chemokine reducing indirectly cell migration towards the infection site 22 . It has been previously demonstrated that the host cells can respond to Enterococcus faecium and E. faecalis infection through the activation of formyl peptide receptor-2 23 , where neutrophils are chemoattracted towards the infection site. In addition, E. faecalis has been shown to produce nonformylated peptides for neutrophil chemoattraction 24 . We found that ElrA affects E. faecalis capacity to form biofilms and diminishes the cohesion between bacteria. Biofilms are usually robust foci resisting host immune defenses 25 . However, planktonic E. faecalis seems less phagocytized when forming biofilm, indicating that the role of enterococcal biofilms in infection is not completely understood 26 . A hypothesis would be that poorly cohesive E. faecalis do not generate appropriate signals to trigger macrophage sensing and migration. The role of ElrA in E. faecalis virulence is well documented and supports a role of ElrA in E. faecalis virulence 5, 9, 10 . Yet, the different mouse genetic backgrounds together with different routes of infection and different kinetics mimicking different stages of the immune response show different effects of ElrA disruption. Accordingly, we observed a minor role of ElrA in the liver of C57BL/6 mice infected by the intravenous route for 24 h. Role of FHL2, a eukaryotic partner of ElrA, in bacterial infection emerges 27 . We were able to show that FHL2 is implicated in host defense against E. faecalis. However, we observed a limited contribution of the interaction between ElrA and FHL2. FHL2 has been linked to pulmonary infection by Schistosoma mansoni where it affects macrophage polarization and modulates granuloma formation 28 . Here, we found that FHL2-deficient macrophages are still able to sense wild type E. faecalis. Non-covalent attachment of WxL proteins, like ElrA, results in the release of unbound proteins in the culture medium 7, 29 . Since FHL2 is found below the plasma membrane, and in the cytosol and nucleus of the cell and ElrA is located at the bacterial surface or released in the culture medium, it is likely that FHL2-ElrA interaction occurs once E. faecalis has been internalized. We propose that ElrA may exert two distinct functions. When bacteria are outside the cells, ElrA acts as an anti-phagocytic cloak, which does not involve FHL2. The other unidentified function would be for internalized bacteria to enhance bacterial survival, a function that would be counteracted by FHL2. Together our results indicate at least a dual function of ElrA depending on the extracellular versus intracellular E. faecalis location during infection.
Methods
Bacterial strains. E. faecalis strains used in this study are listed in Table 1 . E. faecalis was routinely grown in Brain Heart Infusion (BHI) medium at 37 °C without aeration. The P + -ΔelrA strain was complemented for ElrA expression by electroporation with pVE14132 (CPL-elrA) 5 and selected with 10 µg/ml erythromycin. Escherichia −/− mice were infected intravenously with 5 × 10 8 CFUs of OG1RF wild type or ΔelrA strain. The liver, the spleen, and the kidneys were harvested 24 hours post-infection and serial dilutions of organ homogenates were plated on selective enterococci agar medium (BEA). Each dot corresponds to one mouse (n = 12) and were obtained from three independent experiments. Black bars represent median values. Statistical analysis was performed using Mann-Whitney test on three independent experiments. Asterisks indicate a p-value considered statistically significant (*P < 0.05, **P < 0.01, ***P < 0.001).
SCIENtIfIC REPORTS | (2018) 8:1749 | DOI:10.1038/s41598-018-20206-6 coli was grown aerobically in Luria-Bertani (LB) medium at 37 °C. For heterologous ElrA expression, E. coli BL21(DE3) was transformed with the plasmid pVE14047 encoding 6XHis-Tag-ElrA deleted of its signal peptide and selected using 100 µg/ml ampicillin.
Cell lines. The murine Raw 264.7 macrophage cell line was grown in Dulbecco's Modified Eagle Medium (DMEM, Gibco) with 10% decomplemented fetal bovine serum (FBS, Sigma), 2 mM glutamine and 25 mM Hepes. The human ileocecal adenocarcinoma (HCT-8) cell line was grown in DMEM with 10% FBS and 2 mM glutamine. The human placenta choriocarcinoma (Jeg-3), kidney adenocarcinoma (A-704) and liver hepatocellular carcinoma (HepG2) cell lines were grown in Minimum Essential Medium (MEM, Gibco) supplemented with 10% FBS, 2 mM glutamine, 0.1 mM non essential amino acids and 1 mM sodium pyruvate. The human epithelial colorectal adenocarcinoma (Caco-2) cells were grown in MEM with 20% FBS, 2 mM glutamine, 0.1 mM non-essential amino acids and 1 mM sodium pyruvate. The human epitheloid cervix carcinoma (HeLa) and kidney adenocarcinoma (ACHN) cell lines were grown in MEM with 10% FBS, 2 mM glutamine and 0.1 mM non-essential amino acids. L929 cells were grown in DMEM supplemented with glutamine 1 mM, Penicillin and Streptomycin 100 U/ml, HEPES 25 mM and 5% FBS. After 10 days at confluence, cell supernatants containing the M-CSF for monocyte differentiation into macrophages were recovered and centrifuged at 750 g for 10 min. All cells were incubated at 37 °C in 5% CO 2 atmosphere.
Construction of the pVE14047 plasmid.
A DNA fragment containing the elrA open reading frame minus the predicted signal peptide was amplified by PCR from E. faecalis OG1RF genomic DNA using primers OEF275 (5′-CAAACATGTTAGAAACGACCGAAACAATCGC) and OEF276 (5′-TTGGATCCACTCACCCCCTATTTTGC). The resulting PCR fragment was digested with AflIII and BamHI and inserted into the pET2817 vector to generate pVE14047, which encodes the 6xHistidine-tagged-ElrA. After verification by sequencing, pVE14047 was introduced into E. coli BL21 (DE3) and transformants were selected using ampicillin 100 µg/ml.
Expression and purification of ElrA and rabbit anti-ElrA antibodies. Bacterial culture (1 L) of pVE14047-containing E. coli was grown at 23 °C to OD 600 = 0.6. Overexpression of the 6xHis-Tag-ElrA was induced by addition of 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). Bacteria were harvested at OD 600 = 1 by centrifugation at 4000 g for 20 min at 4 °C and resuspended in 17 ml phosphate buffer containing 5 mM imidazole, 10 µg/ml RNAse A (Sigma), 5 µg/ml DNase I (Roche), Halt Protease and Phosphatase inhibitor (Thermo Scientific). Bacteria were disrupted by sonication (20% amplitude) with the Vibro cell 75042 (Bioblock Scientific). Lysates were recovered after centrifugation at 8600 g for 20 min at 4 °C and loaded for 1.5 h on 4 ml of cobalt affinity resin (Ozyme) in 5 mM imidazole. The column was then washed 4 times with a solution of 10 mM imidazole, 300 mM NaCl and 50 mM NaH 2 PO 4 -H 2 O, pH 8, four times in 20 mM imidazole, 300 mM NaCl and 50 mM NaH 2 PO 4 -H 2 O, and twice in 20 mM imidazole, 1 M NaCl, 50 mM NaH 2 PO 4 -H 2 O. ElrA was then eluted with a gradient of imidazole from 50 to 300 mM in 300 mM NaCl and 50 mM NaH 2 PO 4 -H 2 O solution. Purified fractions were dialysed using a Pierce Slide-A-Lysed cassette in 50 mM Tris-HCl, 150 mM NaCl pH 7. Protein extraction and Western blot. All strains were recovered from exponential growth phase (OD 600 = 0.8) by centrifugation at 8600 g for 20 min at 4 °C. Bacterial pellets (1 ml) were diluted in 500 μl of Laemmli buffer containing 0.25 M dithiothreitol (Sigma) and protease inhibitors (Halt cocktail 1×) and kept on ice. Samples were transferred to 2-ml screw-cap micro centrifuge containing silica beads (Lysing Matrix B tubes, MP Biomedicals). Bacteria were disrupted for 45 sec at level 6 with the Fast Prep 24 apparatus (MP Biomedicals). All tubes were then centrifuged at 13500 rpm for 10 min. Soluble protein extracts (50 μl) were separated on a 12% polyacrylamide gel and transferred on a cellulose membrane for 12 min at 25 V and 1.6 A using Pierce G2 Fast Blotter (Thermo Scientific). Membranes were blocked 8 hours using 5% milk in PBS-Tween 0.1%. ElrA was revealed overnight at 4 °C using the enriched fraction of anti-ElrA antibodies (1/100), precleared for 3 h at 4 °C in 500 μl of total protein extract of the ΔElrA strain in PBS tween 0.01%. The day after, we used a secondary goat anti-rabbit antibody conjugated with horseradish peroxidase (#BI 2411, Abliance) at 1:5000 in 5% milk in PBS-Tween 0.1%. Membranes were revealed using Immobilon Western Chemiluminescent HRP Substrates (Millipore) with a ChemiDoc MP system (Bio-Rad).
Zeta potential. Zeta potential of the different E. faecalis strains was measured from bacteria harvested by centrifugation at OD 600 = 0.6 as previously described 30 . Briefly, pellets were washed twice and resuspended in DMEM 1:50 in MilliQ water (Millipore ™ ) and were submitted to an electric voltage (50 V). Electrophoretic motility was measured using a zetaphoremeter (Cad Instruments, Les Essarts le Roy) at pH 7. Mean values and SEM were obtained from two independent experiments.
Polysaccharide analysis. Bacteria were harvested 1 h after the stationary phase, washed and resuspended in 5 mg/ml lysozyme (Sigma) and 250 U/ml mutanolysin (Sigma) in PBS and incubated at 37 °C overnight. Next, polysaccharides were extracted and revealed as previously described 31 .
Electron microscopy. Bacterial pellets harvested at OD 600 = 0.6 were washed with phosphate-buffered saline (PBS) solution and fixed with 2% glutaraldehyde in 0.1 M Na cacodylate buffer pH 7.2, for 1 h at room temperature. Samples were treated as previously described 32 . Thin sections (70 nm) were collected onto 200 mesh copper grids, and counterstained with lead citrate. Grids were examined with Hitachi HT7700 electron microscope operated at 80 kV (Elexience -France), and images were acquired with a charge-coupled device camera (AMT).
Biofilm formation and analysis. Biofilm formation has been investigated as previously described 33 . Briefly, stationary phase E. faecalis cultures were used to freshly inoculate BHI in 96-well microplates (1:100). Bacteria attached to the wells (in triplicate) for 1 h at 37 °C and were washed once with fresh medium. Biofilms developed for 6 h were stained using SYTO 9 (cell permeant nucleic acids dye, Life Technologies) diluted 1:100. Images were acquired using a Leica SP8 confocal laser scanning microscope (Leica Microsystems). The green SYTO 9 emitted fluorescence signal was collected on an hybrid detector in the range 500-550 nm after excitation at 488 nm with an Argon laser set at 20% of its maximal intensity with a z-step of 1 µm and at 600 Hz. 3D reconstructed images were obtained using Imaris (Bitplane) software. Biomass was calculated directly from the raw images using Image J software and Comstat 2 plugin 34 . Percentage of cohesion was calculated by normalizing the remaining biofilm after the three consecutive washes to the initial non-washed biofilm. Statistical tests were performed using unpaired Student's t test on GraphPad Prism.
Cell invasion assay. Two to 5 days before infection, cells were seeded in triplicate in 24-well plates.
Raw267.4 macrophages were activated with 1 µg/ml of purified E. coli lipopolysaccharide (Sigma) for 24 h before bacterial contact. Prior to infection, all cells except macrophages were washed once with PBS and incubated in Krebs-Ringer buffer (Sigma) as described previously 35 . E. faecalis strains were grown to an OD 600 of 0.6, washed twice in PBS and resuspended in medium without serum and used at a multiplicity of infection (MOI) of 5 for macrophages and 50 for epithelial and fibroblastic cells. After 1 min centrifugation at 1000 g and 1 h of contact, cells were washed 4 times with PBS and extracellular bacteria were killed using 150 µg/ml gentamycin and 10 µg/ ml vancomycin antibiotic cocktail. Cells were lysed 1 hour post-infection with 0.5% Triton X-100 and intracellular bacteria enumerated on BHI agar plates. Percentage of invasion was determined as the ratio of intracellular bacteria to the initial inoculum. Statistic tests were performed using unpaired Student's t test on GraphPad Prism.
Bead phagocytosis assay. Raw264.7 macrophages were incubated for 3 hours with the P + -elrA-E strain (MOI 5) as described above or with purified ElrA (10 nM). Next, 0.1 µm fluorescent latex beads (Sigma) were added to an MOI of 5. To synchronize bead phagocytosis, plates were centrifuged 10 min at 400 g. One hour after contact, cells were washed four times with PBS and resuspended in PBS EDTA 2 mM. The percentage of bead-positive cells was determined using a FACSCalibur (BD Biosciences) after gating on live macrophages. Analysis was performed with FlowJo (Tree Star) software.
Macrophage migration. To quantify macrophage migration towards bacteria, we performed a modified Boyden chamber assay 36 . Briefly, Raw264.7 macrophages, or bone marrow derived macrophage (BMDM) generated as previously described 37 , were adapted in 1% FBS containing medium for 6 h and recovered in DMEM without serum. 5 × 10 4 cells were seeded on the upper chamber of a 24-well insert containing a 4 µm polyethylene terephthalate (PET) membrane (Millipore). The elrA isogenic strains (P + -elrA-E, P + -ΔelrA and CPL-elrA) were seeded in the bottom chamber at 5 × 10 5 CFU (eq. to MOI of 10). After ~20 h of incubation, the medium of the upper chamber was plated to verify absence of bacteria. Then, wells were washed twice on PBS and fixed with 3.7% PFA for 2 min. Cells were permeabilised with 100% methanol for 20 min and stained with Giemsa stain for at least 2 h. Migrating cells were trapped in the membrane whereas non-migrating cells were scraped from the upper chamber using a cotton swab. Wells were directly observed using an inverted light microscope. Statistic tests were performed using unpaired Student's t test on GraphPad Prism.
Animal studies. All mice were housed under specific pathogen-free conditions and handled in accordance with French and European directives. Animal experiments were authorized by the Ministry of Education of Higher Education and Research (APAFIS # 480, protocol number 20150415180048149_v1). All mice were on C57BL/6 J background. FHL2 −/− mice have been generated by Chu et al. 38 and have been housed at the CEPR (INSERM U1100, Tours) and at the Pasteur Institute. C57BL6/J control mice were purchased at Charles River. Only conventional 9-to 12-week-old male C57BL6/J and FHL2 −/− mice were used for experiments. E. faecalis OG1RF and ΔelrA strains were collected by centrifugation 1 h after they had reached the stationary phase. Bacterial cells were washed twice with PBS 1× and stored at −80 °C. Mice were infected intravenously in the retro-orbital vein with 5 × 10 8 CFUs. Serial dilutions of the inoculum were plated to control the number of E. faecalis inoculated in mice. The liver, the spleen and the kidneys were recovered 24 hours post-infection. Serial dilutions of organ homogenates were plated on Bile Esculin Agar (BEA) plates, a selective differential agar used to isolate E. faecalis. Statistical analyses were performed using Mann-Whitney test on GraphPad Prism.
